Structural damage to testicular tissue Damage to seminiferous tubules Diabetic patients frequently show significant structural damage in seminiferous tubules, including atrophy, thinning, disorganized epithelial cells, and reduced spermatogenic cell counts [47, 48]
Semaglutide focuses on GLP-1 receptors, while tirzepatide activates both GLP-1 and GIP receptors, offering varied results
RxPros is a telehealth provider with its own separate operations
Key insights from The Atlantic: 14 million adults on Medicaid suffer from obesity, but only 13 states currently cover GLP-1s for weight management These drugs reduce weight by 15-20% and show benefits for diabetes, cardiovascular disease, liver/kidney disease, and even substance abuse Budget fears may be overblown: with Medicaid negotiation power and falling prices, costs could be offset by 27%+ through reduced healthcare spending At projected Medicaid prices (~$235/month), covering 10% of eligible patients would increase Medicaid spending by just 0.4% For communities like zip code 78207 facing a diabetes crisis, this isnt just about weight lossits about access to life-saving medication that could add 3-4 years to life expectancy while reducing complications from multiple chronic conditions
,
If your BMI is between 27-30 you can still be eligible for Tirzepatide if you have another condition that affects your weight such as high cholesterol or blood pressure that limits your ability to exercise
